维普期刊资源整合服务平台（V6.5）

63篇 您的检索式：作者名="Bafaloukos"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Combination of pegylated liposomal doxorubiein(PLD) and paelitaxel in patients with advanced soft tissue sareoma:a phase Ⅱ study of the Hellenic Cooperative Oncology Group显示文摘	Bafaloukos D Papadimitriou C Linardoul H	2004	British Journal of Cancer2004，91，9：	1
2	Neo-adjuvant therapy in breast cancer显示文摘	BAFALOUKOS D	2005	Ann Oncol2005，162，：	1
3	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh U Bafaloukos D	2009	Nat Rev Clin Oncol2009，6，6：	1
4	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh IJ Bafaloukos D	2009	NatRev Clin Oncol2009，6，6：	1
5	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh I J Bafaloukos D et at	2009	Nat Rev Clin Oncol2009，6，6：	1
6	PhaseⅡstudy of docetaxel-vinorelbine in platinum-resistant,paclitaxel-pretreated ovarian cancer显示文摘	Aravantions G Bafaloukos D Fountzilas G	2003	Ann oncol2003，14，7：	1
7	Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group显示文摘	George Fountzilas Dimitrios Pectasides Anna Kalogera-Fountzila Dimosthenis Skarlos Haralambos P. Kalofonos Christos Papadimitriou Dimitrios Bafaloukos Stefanos Lambropoulos Savvas Papadopoulos Helen Kourea Christos Markopoulos Helen Linardou Dimitrios Mav	2005	Breast Cancer Research and Treatment2005，，1：	1
8	Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic Cooperative Oncology Group Phase Ⅱ Study 显示文摘	Fountzilas G Nikoaides C Bafaloukos D	2000	Cancer Invest2000，18，6：	1
9	The treatment of brain metastases in melano- ma Patients 显示文摘	Bafaloukos D Gogas H	2004	Cancer Treat Rev2004，30，6：	1
10	Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa- 2b in patients with reseeted high-risk melanoma显示文摘	Peetasides D Dafni U Bafaloukos D	2009	J Clin Oneol2009，27，6：	1
11	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer显示文摘	Helena Linardou Issa J Dahabreh Dimitra Kanaloupiti Fotios Siannis Dimitrios Bafaloukos Paris Kosmidis Christos A Papadimitriou Samuel Murray	2008	Lancet Oncology2008，，10：	1
12	Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcima:a phase Ⅱ study of the Hellenic Cooperative Oncology Group 显示文摘	Bafaloukos D Papadimitriou C Linardou H	2004	Br J Cancer2004，91，9：	1
13	Randomized phase III study of I month versus 1 year of adjuvant high-dose interferon alfa- 2b in patients with resected high-risk melanoma 显示文摘	Pectasides D Dafni U Bafaloukos D	2009	J Clin Oncol2009，27，6：	1
14	Metastatic breast cancer with liver metastases : a registry analysis of clinico- pathologic, management and outcome characteristics of 500women 显示文摘	Pentheroudakis G Fountzilas G Bafaloukos D	2006	Breast Cancer Res Treat2006，97，3：	1
15	All about KRAS for clinical oncology practice: Gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer显示文摘	Helena Linardou Evangelos Briasoulis Issa J. Dahabreh Giannis Mountzios Christos Papadimitriou Savvas Papadopoulos Dimitrios Bafaloukos Paris Kosmidis Samuel Murray	2010	Cancer Treatment Reviews2010，，3：	1
16	Paclitaxel,epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: A Hellenic Cooperative Oncology Group(HeCOG) study显示文摘	Bafaloukos D Bozas G Kalofonos H	2008	Gynecol Oncol2008，110，1：	1
17	Paclitaxel,topotecan,and carboplatin in metastatic endometrial cancinoma:a hellenic co-operative oncology group(HeCOG)study显示文摘	Papadimitriou CA Fountzilas G Bafaloukos D	2008	Gynecologic Oncology2008，111，1：	1
18	All about KRAS for clinical oncology practice: Gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer显示文摘	Helena Linardou Evangelos Briasoulis Issa J. Dahabreh Giannis Mountzios Christos Papadimitriou Savvas Papadopoulos Dimitrios Bafaloukos Paris Kosmidis Samuel Murray	2010	Cancer Treatment Reviews2010，，3：	1
19	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted a- gents:a systematic review and recta-analysis of studies in ad- vanced non-small-cell lung cancer and metastatic colorectal cancer显示文摘	Linardou H Dahabreh I J Kanaloupiti D Siannis F Bafaloukos D Kosmidis P	2008	Lancet Oncol2008，9，：	1
20	Improved Outcome of High-Risk Early HER2 Positive Breast Cancer With High CXCL13-CXCR5 Messenger RNA Expression显示文摘	Evangelia Razis Konstantine T. Kalogeras Vassiliki Kotoula Anastasia G. Eleftheraki Nikitas Nikitas Ralf Kronenwett Eleni Timotheadou Christos Christodoulou Dimitrios Pectasides Helen Gogas Ralph M. Wirtz Thomas Makatsoris Dimitrios Bafaloukos Gerasimos A	2012	Clinical Breast Cancer2012，，3：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示